US HB4633 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on October 11 2019 - 25% progression, died in committee
Action: 2019-10-14 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To amend the 21st Century Cures Act to reauthorize funding for FDA innovation projects, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Investing in Safety and Innovation Act of 2019

Sponsors


History

DateChamberAction
2019-10-14HouseReferred to the Subcommittee on Health.
2019-10-11HouseReferred to the House Committee on Energy and Commerce.
2019-10-11HouseIntroduced in House

Same As/Similar To

HB3 (Related) 2020-09-08 - Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.

Subjects


US Congress State Sources


Bill Comments

feedback